Cap table
Built by 6ix from Revive Therapeutics Ltd.’s releases · as of Aug 14, 2026
- Common shares
- 444,613,939
- Fully diluted
- 472,719,870
Fully diluted
| Line | Shares | As of |
|---|
| Common shares | 444,613,939 | Jul 15, 2026 |
|---|
| Warrants | 12,605,931 | Jul 15, 2026 |
|---|
| Options and RSUs | 15,500,000 | Aug 14, 2026 |
|---|
Warrants and options
| Lot |
|---|
| Warrants · C$0.05 · expire about Jul 2029 |
|---|
| Warrants · C$0.05 · expire about Aug 2028 |
|---|
| Broker warrants · C$0.05 · expiry not stated |
|---|
| Broker warrants · C$0.05 · expiry not stated |
|---|
| Stock options · C$0.05 · expire about Aug 2031 |
|---|
Share count over time
| Count | Shares |
|---|
| Nov 22, 2026 | 444,613,939 |
|---|
| Jul 15, 2026 | 443,392,423 |
|---|
| Jun 30, 2026 | 435,676,173 |
|---|